Detailed results from RISE UP Phase 3 trial of mitapivat in sickle cell disease selected for distinguished Plenary Abstracts Session; Company to host investor conference call and ...
Additionally, the approval provides for a revision of ASCENIV’s prescribing information to expand the primary humoral immunodeficiency (“PI”) indication to pediatric patients two years of age and ...
Q 2026 Total Revenue of $114.5 Million, Flat Year-Over-Year 1Q 2026 ASCENIV Revenue +28% Year-Over-Year; BIVIGAM Revenue -54% Year-Over-Year1Q ...
BACKGROUND: The optimal transfusion strategy in patients with acute myocardial infarction (AMI) and anemia may be influenced by sex differences in pathophysiology and cardiovascular outcomes. The ...
A 50-year-old woman was admitted to the hospital because of vaginal bleeding and anemia. She had a history of fibroids and 1 ...
Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the supplemental Biologics License Application (sBLA) for IMAAVY® (nipocalimab-aahu),c ...
GC Biopharma USA, Inc., a leader in plasma-derived products, announced today the presentation of new data at the 2026 ...
A new meta-analysis of 13 studies has found that psilocybin consistently slows reaction times and mildly impairs executive function during its acute phase, with effects scaling by dose. While accuracy ...
Since iOS 17 and iPadOS 17, Apple has included Messages-like reactions in FaceTime that lighten up your video with visual effects. But rather than triggering them with words, you can trigger them ...
The management of patients with hemolytic uremic syndrome is challenging, and strategies for accurate diagnosis and effective treatment are needed. Intensive research over the past several years has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results